Short description
StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection.
Description
StageZero Life Sciences is a biotech company developing and commercializing blood-based diagnostic tests for early disease detection. The company next-generation test, Aristotle, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on its proprietary mRNA technology platform, which was validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer.
StageZero Life Sciences was founded in 1998 and is based in Richmond Hill, Ontario, Canada.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Richmond Hill, Ontario, Canada, North America
Founded on
January 1, 1998
Exited on
July 12, 2021
Went public on
July 12, 2021
Stock symbol
SZLSF
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noway Youcantaccess
Sign in for full access
Founders
Choong-Chin Liew, K. Wayne Marshall